TRVI
#1845
Trevi Therapeutics, Inc. - Common Stock
17.9 1 USD
+0.08%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+8.41%
Variación mensual
+22.09%
Variación en los últimos 6 meses
+65.83%
Cambio anual
+161.08%
Cierres anteriores
16.5 2
Open
17.9 0
Mínimo
17.9 0
High
17.9 1
Volumen
113
Financials
- Market Capitalization 2.54 B
- Employee 34
- Founded 2011
- CEO N/A
- Website www.trevitherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG003QGQRB9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1821 |  QURE uniQure N.V. - Ordinary Shares | 41.52 USD | +1.02% | +0.24% | +49.73% | +195.10% | 2.62 B USD | ||
| 1837 |  IMNM Immunome, Inc. - Common Stock | 22.59 USD | -0.92% | -6.54% | +25.29% | +163.59% | 2.56 B USD | ||
| 1856 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 13.39 USD | +6.10% | -6.36% | +76.18% | +597.40% | 2.49 B USD | ||
| 1860 |  BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.74 USD | -1.72% | -11.05% | +7.15% | +11.31% | 2.48 B USD |